Q2 2024 |
202 |
$316M |
+$117M |
-$143M |
-$26M |
HES, ACI, CPRI, AMED, CCIX
|
13F-HR |
8/14/2024, 10:03 AM |
Q1 2024 |
221 |
$342M |
+$151M |
-$109M |
+$42.9M |
SCRM, PXD, AMED, ACI, TRTLF
|
13F-HR |
5/13/2024, 11:31 AM |
Q4 2023 |
212 |
$273M |
+$137M |
-$126M |
+$10.6M |
AMED, RPT, LCAA, CVII, SRC
|
13F-HR |
2/13/2024, 06:58 PM |
Q3 2023 |
212 |
$267M |
+$136M |
-$102M |
+$33.9M |
ATVI, HZNP, AAC, SGEN, ACI
|
13F-HR |
11/13/2023, 06:58 PM |
Q2 2023 |
211 |
$235M |
+$190M |
-$76.5M |
+$114M |
ATVI, SGEN, HZNP, FLD, ACI
|
13F-HR |
8/14/2023, 03:41 PM |
Q1 2023 |
194 |
$121M |
+$94.6M |
-$89.2M |
+$5.47M |
KVSC, IXAQ, APEN, HZNP, CIIG
|
13F-HR |
5/12/2023, 06:07 PM |
Q4 2022 |
171 |
$115M |
$0 |
$0 |
|
STOR, EVOP, COWN, MYOV, VMW
|
13F-HR |
2/13/2023, 06:19 PM |